Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.33 |
| ▸ | TXNRD1 | Q16881 | 1/20 | 0.31 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.30 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL329285 | 0.88 | — | — | |
| SCHEMBL30821606 | 0.88 | L3MBTL1 (0.38) | L3MBTL1TXNRD1ALDH1A1SMN1; SMN2 | |
| SCHEMBL28284121 | 0.86 | L3MBTL1 (0.37) | L3MBTL1TXNRD1ALDH1A1SMN1; SMN2 | |
| Hydrochloric Acid SCHEMBL27594552 | 0.86 | L3MBTL1 (0.37) | L3MBTL1TXNRD1ALDH1A1SMN1; SMN2 | |
| Ammonia Solution, Strong SCHEMBL28075036 | 0.86 | L3MBTL1 (0.37) | L3MBTL1TXNRD1ALDH1A1SMN1; SMN2 | |
| Biphenyl SCHEMBL27540404 | 0.76 | MTOR (0.48) | L3MBTL1ALDH1A1SMN1; SMN2 | |
| Acrylic Acid SCHEMBL28248820 | 0.75 | LMNA (0.34) | L3MBTL1TXNRD1ALDH1A1 | |
| SCHEMBL8408066 | 0.74 | ALDH1A1 (0.32) | TXNRD1ALDH1A1SMN1; SMN2 | |
| Toluene SCHEMBL28778070 | 0.74 | NPC1 (0.41) | L3MBTL1TXNRD1ALDH1A1SMN1; SMN2 | |
| Benzil SCHEMBL28006897 | 0.73 | CES2 (0.45) | L3MBTL1ALDH1A1SMN1; SMN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10059704-B2 | 1,4-disubstituted 1,2,3-triazoles, methods for preparing same, and diagnostic and therapeutic uses thereof | CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (C.N.R.S.) (FR) | 2018-08-28 | — | — | US | disclosed |
| US-20140030191-A1 | 1,4-DISUBSTITUTED 1,2,3-TRIAZOLES, METHODS FOR PREPARING SAME, AND DIAGNOSTIC AND THERAPEUTIC USES THEREOF | CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (C.N.R.S.) (FR) | 2014-01-30 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20140030191-A1 | 1,4-DISUBSTITUTED 1,2,3-TRIAZOLES, METHODS FOR PREPARING SAME, AND DIAGNOSTIC AND THERAPEUTIC USES THEREOF | CYP3A43, NAT1, UGT1A1 | L3MBTL1 4758/4885TXNRD1 2488/4885ALDH1A1 258/4885 |
| US-10059704-B2 | 1,4-disubstituted 1,2,3-triazoles, methods for preparing same, and diagnostic and therapeutic uses thereof | CYP3A43, NAT1, UGT1A1 | L3MBTL1 4758/4885TXNRD1 2488/4885ALDH1A1 258/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.